LIFE - aTyr Pharma, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
3.95
-0.15 (-3.66%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close4.10
Open4.13
Bid3.35 x 5000
Ask4.25 x 1000
Day's Range3.95 - 4.13
52 Week Range2.30 - 6.50
Volume10,577
Avg. Volume41,895
Market Cap117.545M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press2 months ago

    Atyr Pharma reports 3Q loss

    The San Diego-based company said it had a loss of 43 cents per share. The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for ...

  • Zacks.com featured highlights include article Kraton, aTyr Pharma, Grupo Financiero Galicia, Grupo Supervielle and Calithera Biosciences
    Zacks3 months ago

    Zacks.com featured highlights include article Kraton, aTyr Pharma, Grupo Financiero Galicia, Grupo Supervielle and Calithera Biosciences

    Zacks.com featured highlights include article Kraton, aTyr Pharma, Grupo Financiero Galicia, Grupo Supervielle and Calithera Biosciences

  • How Should You Think About aTyr Pharma Inc’s (LIFE) Risks?
    Simply Wall St.4 months ago

    How Should You Think About aTyr Pharma Inc’s (LIFE) Risks?

    For aTyr Pharma Inc’s (NASDAQ:LIFE) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. The beta measuresRead More...

  • Associated Press5 months ago

    Atyr Pharma reports 2Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 51 cents. In the final minutes of trading on Monday, the company's shares hit $3.25. A year ago, they were trading at $3.42. _____ ...

  • Associated Press8 months ago

    Atyr Pharma reports 1Q loss

    The San Diego-based company said it had a loss of 56 cents per share. In the final minutes of trading on Thursday, the company's shares hit $3.10. A year ago, they were trading at $3.01. _____ This story ...

  • Associated Press10 months ago

    Atyr Pharma reports 4Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 53 cents. For the year, the company reported a loss of $57.9 million, or $2.44 per share. In the final minutes of trading on Thursday, ...

  • Investopedia11 months ago

    aTyr Pharma Rises 16% on Orphan Drug Status

    Atyr Pharma was granted orphan drug status for its Resolaris muscular dystrophy drug.

  • Associated Press11 months ago

    High court ruling limits international reach of patent laws

    WASHINGTON (AP) — The Supreme Court on Wednesday sided with California-based Life Technologies Corp. in a patent infringement case that limits the international reach of U.S. patent laws.